Work

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.4276.4276

Authors: Dudley Pennell, John B. Porter, Maria Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi-Kong Li, Vip Viprakasit, Mohsen Saleh Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Ali Taher

Institutions: Royal Brompton Hospital, University College London, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University Malaya Medical Centre, Cairo University, Ege University, Hospital Kuala Lumpur, Prince of Wales Hospital, Siriraj Hospital, Mahidol University, Ain Shams University, National and Kapodistrian University of Athens, Novartis (Switzerland), American University of Beirut

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1687673757

FWCI: 1.767

Cites:

Cited by: 8

Related to: 10